Accutar Biotech

Accutar Biotech was founded in 2015, is headquartered in New York, United States, lists 11–50 employees, and has $28.0M in recorded funding across 2 rounds.

Headquarters
New York
Employees
11–50
Founded
2015
Business Model
B2B
Total Funding
$28.0M
Last Round
Series BApr 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 2 investors for this company. The full record is or through the API.

About

Accutar Biotech is a clinical-stage, AI-empowered drug discovery company headquartered in Brooklyn, New York, founded in 2015 by CEO Jie Fan. The company applies deep learning and computational chemistry to explain the physical and chemical nature of biological systems, powering a pipeline of small-molecule and targeted protein degradation programs, including AC0682, which is in Phase 1 trials for ER-positive breast cancer.

Summary

Accutar Biotech is an Artificial Intelligence company based in New York, United States, founded in 2015. It lists 11–50 employees. It has raised $28.0M in total across 2 rounds, most recently a Series B round in Apr 2021. Investors include Yunfeng Capital and Coatue Management.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BApr 2021

Sign up to see all 2 events

Funding: Series B. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Devoted Health

Next-gen Medicare Advantage insurance plan with AI-forward medical group delivering quality and s...

Waltham, United States1001–5000Artificial Intelligence, Healthcare
Series G+Total funding$3.5BOct 2026
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Verily Life Sciences

Verily builds AI-native precision health platforms that help healthcare organizations harmonize d...

Dallas, United States1001–5000Artificial Intelligence, Healthcare
Corporate RoundTotal funding$3.0BMar 2026
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Accutar Biotech on Indexed.vc
<a href="https://indexed.vc/companies/accutar-biotech"><img src="https://indexed.vc/api/badge/company/accutar-biotech" alt="Accutar Biotech on Indexed.vc" width="260" height="76" /></a>